Beam Therapeutics Inc. (BEAM) vs Precigen, Inc. (PGEN)
A side-by-side comparison of Beam Therapeutics Inc. and Precigen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BEAM
Beam Therapeutics Inc.
$25.34HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
PGEN
Precigen, Inc.
$7.60HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — BEAM vs PGEN
growth of $100 · dividends reinvested · last 7yBEAM +36.9% (+4.6%/yr)PGEN +53.3% (+6.3%/yr)PGEN compounded faster over this window
BEAM PGEN
BEAM vs PGEN: by the numbers
- •PGEN is the larger company ($2.71B vs $2.61B market cap).
- •Both run net losses; BEAM's is the smaller (-54.75% vs -183.98% net margin).
- •BEAM grew revenue faster over the past five years (479.04% vs -21.26% CAGR).
Metrics side by side
Valuation
| Metric | BEAM | PGEN |
|---|---|---|
| Forward P/E | N/A | 44.32 |
| P/S ratio | 16.71 | 31.59 |
| P/B ratio | 2.44 | 62.14 |
Profitability
| Metric | BEAM | PGEN |
|---|---|---|
| Gross margin | 84.05% | 37.05% |
| Operating margin | -274.57% | -1100.78% |
| Net margin | -54.75% | -183.98% |
| ROE | -8.00% | -361.91% |
| ROIC | -28.96% | -28.02% |
Growth (annualized)
| Metric | BEAM | PGEN |
|---|---|---|
| Revenue CAGR (5Y) | 479.04% | -21.26% |
| Total return CAGR (5Y) | -21.41% | 8.79% |
Frequently asked
- Which has grown faster, BEAM or PGEN?
- Over the past five years, BEAM grew revenue faster — BEAM at a 479.04% CAGR versus PGEN at -21.26%.
- How have BEAM and PGEN total returns compared?
- Over the past 5 years, BEAM delivered -21.41% and PGEN delivered 8.79% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Beam Therapeutics ROEPrecigen ROEBeam Therapeutics operating marginPrecigen operating marginBeam Therapeutics revenue growthPrecigen revenue growthBeam Therapeutics free cash flowPrecigen free cash flow
Beam Therapeutics & Precigen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.